0.3508
Vyne Therapeutics Inc Aktie (VYNE) Neueste Nachrichten
Is VYNE Therapeutics Inc. stock poised for growthMarket Risk Analysis & Low Risk High Reward Trade Ideas - Newser
Price action breakdown for VYNE Therapeutics Inc.Bear Alert & Daily Price Action Insights - Newser
VYNE Stock Update: VYNE Therapeutics Inc’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com
Risk vs reward if holding onto VYNE Therapeutics Inc.Gap Down & Low Risk Growth Stock Ideas - Newser
VYNE Therapeutics Reports Q2 2025 Financials and Updates - TipRanks
Will breakout in VYNE Therapeutics Inc. lead to full recoveryEntry Point & Verified Momentum Watchlists - Newser
Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update | VYNE Stock News - GuruFocus
VYNE (VYNE) reports quarter results; two directors resign - Stock Titan
VYNE's Psoriasis Drug Shows Promise as FDA Partially Lifts Clinical Hold, Cash Position Strengthens - Stock Titan
Is VYNE Therapeutics Inc. reversing from oversold territoryShare Buyback & Safe Swing Trade Setups - Newser
Does VYNE Therapeutics Inc. stock pay reliable dividendsRecession Risk & AI Based Trade Execution Alerts - Newser
Is VYNE Therapeutics Inc. stock entering bullish territoryJuly 2025 Retail & Free High Return Stock Watch Alerts - Newser
Is VYNE Therapeutics Inc. trending in predictive chart modelsConservative Investment Setup and Risk Analysis - Newser
Volume Surge May Signal Institutional Interest in VYNE Therapeutics Inc.Breakout Confirmation With Entry Tracker Enabled - 선데이타임즈
Technical analysis overview for VYNE Therapeutics Inc. stockSector Rotation and Stock Opportunity Analysis - Newser
What makes VYNE Therapeutics Inc. stock price move sharplyStrong ROI Equity Ideas - thegnnews.com
Aquestive Therapeutics Q2 Earnings Miss Estimates, Revenue Down 50% YoY - AInvest
VYNE Therapeutics (VYNE) Projected to Post Quarterly Earnings on Wednesday - Defense World
Does VYNE Therapeutics Inc. show high probability of reboundTechnical Trade Plan with Entry Checklist - Newser
Will earnings trigger a reversal in VYNE Therapeutics Inc.Free Weekly Hot Picks With Buy Confidence - Newser
A Quick Look at Today's Ratings for VYNE Therapeutics(VYNE.US), With a Forecast Between $2 to $2 - 富途牛牛
Vyne Therapeutics Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
How to read the order book for VYNE Therapeutics Inc.Equity Performance Forecast Based on AI Models - Newser
Chart based exit strategy for VYNE Therapeutics Inc.Earnings Impact and Stock Reaction Analysis - Newser
How VYNE Therapeutics Inc. stock performs during market volatilityStock Trading Session Highlights and Summary - Newser
Real time pattern detection on VYNE Therapeutics Inc. stockFree Weekly Return Pick Forecast Reports - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):